Embraer (EMBR3) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
5 Jun, 2025Executive summary
Achieved record revenue of $6.4 billion in 2024, the highest in company history, with all business units contributing to growth.
Backlog reached an all-time high of $26.3 billion, up 40% year-over-year, reflecting strong demand and a 2.2 book-to-bill ratio.
Net debt nearly eliminated, with net debt-to-EBITDA at 0.1x, and Moody’s upgraded to investment grade.
All 2024 operational and financial guidance targets met or exceeded, with 206 aircraft delivered (+14% yoy).
Largest-ever executive aviation order: $7 billion Flexjet contract for 182 aircraft.
Financial highlights
Net revenues rose 21% year-over-year to $6,395 million in 2024, with 4Q24 revenue at $2,311 million (+17% yoy).
Adjusted EBITDA for 2024 was $921.6 million (14.4% margin), up from $561.9 million (10.7%) in 2023.
Adjusted EBIT reached $708 million (11.1% margin), up from $350 million (6.6%) in 2023; adjusted net results were $462 million (7.2% margin).
Adjusted free cash flow (ex-Eve) was $676 million for 2024, well above guidance, aided by defense prepayments.
Consolidated cash position at year-end was $2,551 million.
Outlook and guidance
2025 revenue guidance: $7.0–$7.5 billion (+13% yoy midpoint).
2025 adjusted EBIT margin guidance: 7.5%–8.3%, with free cash flow expected at $200 million or higher.
Commercial aviation deliveries projected at 77–85 (+10% yoy midpoint); executive aviation at 145–155 (+15% yoy midpoint).
Guidance reflects realistic production plans amid ongoing supply chain constraints.
Combined 2024–2025 free cash flow expected to reach $875 million, targeting 50% EBITDA conversion.
Latest events from Embraer
- Record revenue, historic backlog, and double-digit growth signal continued expansion.EMBR3
Q4 20256 Mar 2026 - Record backlog and robust growth across aviation, defense, and urban air mobility segments.EMBR3
Investor presentation6 Mar 2026 - Record revenue and $31.3B backlog in 3Q25, with 2025 guidance reaffirmed.EMBR3
Q3 20253 Feb 2026 - Q2 revenue up 15%+, backlog at $21.1B, margins improved, guidance reiterated, strong segment growth.EMBR3
Q2 20242 Feb 2026 - Record backlog and 32% revenue growth drive higher margins and upgraded 2024 guidance.EMBR3
Q3 202415 Jan 2026 - Backlog hit $22.7B, with strong growth, margin expansion, and innovation driving 2024 outlook.EMBR3
Investor Day 202413 Jan 2026 - Record Q1 revenue, backlog, and margins drive strong 2025 outlook despite tariff risks.EMBR3
Q1 202524 Nov 2025 - Record Q2 revenue, backlog, and margins achieved, with guidance maintained despite risks.EMBR3
Q2 202523 Nov 2025